Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden.
Gabriella BrömsHelle KielerAnders EkbomGissler MikaKarin HellgrenAnna-Maria Lahesmaa-KorpinenLars PedersenMarcus Schmitt-EgenolfHenrik Toft SorensenFredrik GranathPublished in: Pharmacoepidemiology and drug safety (2020)
Anti-TNF agents were associated with increased risks of preterm birth, caesarean section, and small for gestational age. However, the diverse findings across disease groups may indicate an association related to the underlying disease activity, rather than to agent-specific effects.